Stage IV Ovarian Cancer
Showing 1 - 25 of 46
Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)
Enrolling by invitation
- Stage III Vulvar Cancer
- +7 more
- Intervention group triads
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Aug 10, 2023
Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)
Not yet recruiting
- Ovarian Cancer
- +3 more
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jul 18, 2023
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)
Not yet recruiting
- Stage III Ovarian Cancer
- +5 more
- Cisplatin
- No treatment
- (no location specified)
Dec 12, 2022
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)
Recruiting
- Stage III Ovarian Cancer
- +6 more
- Cytoreductive Surgery (CRS)
- +6 more
-
Baltimore, MarylandMercy Medical Center
Aug 30, 2022
Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,
Recruiting
- Ovarian Cancer
- +13 more
- Mind-body resilience training
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Jun 28, 2022
Stage IV Ovarian Cancer, Testis Cancer, Refractory, Endometrial Cancer Recurrent Trial in Guangzhou (Claudin6 targeting CAR-NK
Recruiting
- Stage IV Ovarian Cancer
- +3 more
- Claudin6 targeting CAR-NK cells
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Jun 5, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,
Terminated
- Stage III Fallopian Tube Cancer
- +14 more
- Carboplatin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 17, 2021
Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Dallas (Vigil™ Vaccine, Bevacizumab)
Completed
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- Vigil™ Vaccine
- Bevacizumab
-
Dallas, TexasMary Crowley Cancer Research Centers
Oct 15, 2021
Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)
Recruiting
- Stage II Breast Cancer
- +22 more
- Behavioral Intervention
-
Bay City, Michigan
- +7 more
Sep 29, 2021
Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)
Completed
- Fallopian Tube Carcinoma
- +14 more
- Diagnostic Microscopy
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 5, 2021
Metastatic Ovarian Carcinoma, Peritoneal Carcinomatosis, Stage III Ovarian Cancer Trial in Pierre-Bénite (Combined PIPAC / IV
Recruiting
- Metastatic Ovarian Carcinoma
- +6 more
- Combined PIPAC / IV chemotherapy treatment
-
Pierre-Bénite, FranceCentre Hospitalier Lyon Sud
Aug 4, 2021
Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma
Active, not recruiting
- Recurrent Malignant Solid Neoplasm
- +15 more
- Canady Helios Cold Plasma Scalpel
-
Washington, District of ColumbiaCanady Surgical Group PC
Jul 16, 2021
Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (18F-DCFPyL)
Recruiting
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- 18F-DCFPyL
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Mar 31, 2021
Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Boston (Culdocentesis, Vaginal Swab, Chromopertubation)
Terminated
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- Culdocentesis
- +4 more
-
Boston, Massachusetts
- +1 more
May 1, 2020
Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Japan, Korea, Republic of,
Completed
- Ovarian Clear Cell Cystadenocarcinoma
- +2 more
- Carboplatin
- +4 more
-
Phoenix, Arizona
- +144 more
Aug 6, 2019
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Completed
- Fallopian Tube Clear Cell Adenocarcinoma
- +26 more
- Bevacizumab
- +5 more
-
Anniston, Alabama
- +631 more
Jul 19, 2019
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
Primary Peritoneal Carcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Philadelphia (Paclitaxel, Carboplatin,
Completed
- Primary Peritoneal Carcinoma
- +2 more
- Paclitaxel
- +5 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Apr 3, 2019
Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,
Completed
- Adult Hepatocellular Carcinoma
- +44 more
- Bevacizumab
- Temsirolimus
-
Scottsdale, Arizona
- +60 more
Jan 24, 2019
Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor Trial in
Completed
- Fallopian Tube Carcinoma
- +7 more
- Belinostat
- Laboratory Biomarker Analysis
-
Hamilton, Ontario, Canada
- +3 more
Jul 20, 2018
Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Dallas (Vigil™ Vaccine, Carboplatinum, Carboplatinum and Taxol)
Completed
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- Vigil™ Vaccine
- +2 more
-
Dallas, TexasMary Crowley Cancer Research Centers
May 21, 2018
Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer Trial (drug, procedure, other)
Withdrawn
- Stage IIIA Fallopian Tube Cancer
- +11 more
- (S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid (18F-FSPG)
- +2 more
- (no location specified)
Jun 4, 2018
Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,
Terminated
- Nausea and Vomiting
- +26 more
- Adjuvant Therapy
- +7 more
-
Hinsdale, Illinois
- +1 more
Apr 24, 2018